Registro:

Referencias:

• Arrondeau, J., Huillard, O., Tlemsani, C., Cessot, A., Boudou-Rouquette, P., Blanchet, B., Thomas-Schoemann, A., Goldwasser, F., Investiga-tional therapies up to phase II which target PDGF receptors: Potential anti-cancer therapeutics (2015) Expert Opin Investig Drugs, 24 (5), pp. 673-687
• Barbi, J., Pardoll, D., Pan, F., Metabolic control of the Treg/Th17 axis (2013) Immunol Rev, 252 (1), pp. 52-77
• Batchelor, T.T., Sorensen, A.G., Di Tomaso, E., Zhang, W.T., Duda, D.G., Cohen, K.S., Kozak, K.R., Jain, R.K., AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients (2007) Cancer Cell, 11 (1), pp. 83-95
• Bergers, G., Hanahan, D., Modes of resistance to anti-angiogenic therapy (2008) Nat Rev Cancer, 8 (8), pp. 592-603
• Birbrair, A., Zhang, T., Wang, Z.M., Messi, M.L., Enikolopov, G.N., Mintz, A., Delbono, O., Skeletal muscle pericyte subtypes differ in their differentiation potential (2013) Stem Cell Res, 10 (1), pp. 67-84
• Bose, A., Barik, S., Banerjee, S., Ghosh, T., Mallick, A., Bhattacharyya Majumdar, S., Goswami, K.K., Majumdar, S., Tumor-derived vascular pericytes anergize Th cells (2013) J Immunol, 191 (2), pp. 971-981
• Bourbie-Vaudaine, S., Blanchard, N., Hivroz, C., Romeo, P.H., Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer (2006) J Immunol, 177 (3), pp. 1460-1469
• Brecht, K., Weigert, A., Hu, J., Popp, R., Fisslthaler, B., Korff, T., Fleming, I., Brune, B., Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2 (2011) FASEB J, 25 (7), pp. 2408-2417
• Bruno, A., Focaccetti, C., Pagani, A., Imperatori, A.S., Spagnoletti, M., Rotolo, N., Cantelmo, A.R., Noonan, D.M., The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer (2013) Neoplasia, 15 (2), pp. 133-142
• Burke, B., Tang, N., Corke, K.P., Tazzyman, D., Ameri, K., Wells, M., Lewis, C.E., Expression of HIF-1alpha by human macrophages: Implications for the use of macrophages in hypoxia-regulated cancer gene therapy (2002) J Pathol, 196 (2), pp. 204-212
• Carbone, C., Tamburrino, A., Piro, G., Boschi, F., Cataldo, I., Zanotto, M., Mina, M.M., Melisi, D., Combined inhibition of IL1, CXCR1/2, and TGFbeta signaling pathways modulates in-vivo resistance to anti-VEGF treatment (2016) Anti-Cancer Drugs, 27 (1), pp. 29-40
• Carlini, M.J., Roitman, P., Nunez, M., Pallotta, M.G., Boggio, G., Smith, D., Salatino, M., Puricelli, L.I., Clinical relevance of galectin-1 expression in non-small cell lung cancer patients (2014) Lung Cancer, 84 (1), pp. 73-78
• Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases (2000) Nature, 407 (6801), pp. 249-257
• Carmeliet, P., Jain, R.K., Molecular mechanisms and clinical applications of angiogenesis (2011) Nature, 473 (7347), pp. 298-307
• Casanovas, O., Hicklin, D.J., Bergers, G., Hanahan, D., Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors (2005) Cancer Cell, 8 (4), pp. 299-309
• Cerliani, J.P., Blidner, A.G., Toscano, M.A., Croci, D.O., Rabinovich, G.A., Translating the ‘sugar code’ into immune and vascular signaling programs (2016) Trends Biochem Sci
• Chan, D.A., Kawahara, T.L., Sutphin, P.D., Chang, H.Y., Chi, J.T., Giaccia, A.J., Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment (2009) Cancer Cell, 15 (6), pp. 527-538
• Chandler, K.B., Leon, D.R., Meyer, R.D., Rahimi, N., Costello, C.E., Site-specific N-glycosylation of endothelial cell receptor tyrosine kinase VEGFR-2 (2017) J Proteome Res, 16 (2), pp. 677-688
• Chen, C., Duckworth, C.A., Fu, B., Pritchard, D.M., Rhodes, J.M., Yu, L.G., Circulating galectins-2,-4 and-8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis (2014) Br J Cancer, 110 (3), pp. 741-752
• Chen, W.S., Cao, Z., Sugaya, S., Lopez, M.J., Sendra, V.G., Laver, N., Leffler, H., Panjwani, N., Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3 (2016) Nat Commun, 7
• Chouaib, S., Messai, Y., Couve, S., Escudier, B., Hasmim, M., Noman, M.Z., Hypoxia promotes tumor growth in linking angiogenesis to immune escape (2012) Front Immunol, 3
• Chung, A.S., Wu, X., Zhuang, G., Ngu, H., Kasman, I., Zhang, J., Vernes, J.M., Ferrara, N., An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy (2013) Nat Med, 19 (9), pp. 1114-1123
• Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., Jairam, V., Cyrus, N., Medzhitov, R., Functional polarization of tumour-associated macrophages by tumour-derived lactic acid (2014) Nature, 513 (7519), pp. 559-563
• Cooke, V.G., Lebleu, V.S., Keskin, D., Khan, Z., O’Connell, J.T., Teng, Y., Duncan, M.B., Kalluri, R., Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway (2012) Cancer Cell, 21 (1), pp. 66-81
• Corzo, C.A., Condamine, T., Lu, L., Cotter, M.J., Youn, J.I., Cheng, P., Cho, H.I., Gabrilovich, D.I., HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment (2010) J Exp Med, 207 (11), pp. 2439-2453
• Coussens, L.M., Raymond, W.W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G.H., Hanahan, D., Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis (1999) Genes Dev, 13 (11), pp. 1382-1397
• Coussens, L.M., Zitvogel, L., Palucka, A.K., Neutralizing tumor-promoting chronic inflammation: A magic bullet? (2013) Science, 339 (6117), pp. 286-291
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J., Rabinovich, G.A., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma (2012) J Exp Med, 209 (11), pp. 1985-2000
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Mendez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Toscano, M.A., Rabinovich, G.A., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156 (4), pp. 744-758
• Croci, D.O., Cerliani, J.P., Pinto, N.A., Morosi, L.G., Rabinovich, G.A., Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment (2014) Glycobiology, 24 (12), pp. 1283-1290
• Curiel, T.J., Cheng, P., Mottram, P., Alvarez, X., Moons, L., Evdemon-Hogan, M., Wei, S., Zou, W., Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer (2004) Cancer Res, 64 (16), pp. 5535-5538
• D’Alessio, F.R., Zhong, Q., Jenkins, J., Moldobaeva, A., Wagner, E.M., Lung angiogenesis requires CD4(+) forkhead homeobox protein-3(+) regulatory T cells (2015) Am J Respir Cell Mol Biol, 52 (5), pp. 603-610
• D’Haene, N., Sauvage, S., Maris, C., Adanja, I., Le Mercier, M., Decaestecker, C., Baum, L., Salmon, I., VEGFR1 and VEGFR2 involvement in extracellular galectin-1-and galectin-3-induced angiogenesis (2013) Plos One, 8 (6)
• Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Pan, F., Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 (2011) Cell, 146 (5), pp. 772-784
• de Palma, M., Venneri, M.A., Galli, R., Sergi Sergi, L., Politi, L.S., Sampaolesi, M., Naldini, L., Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors (2005) Cancer Cell, 8 (3), pp. 211-226
• Delgado, V.M., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernandez, M.M., Malchiodi, E.L., Frahm, I., Elola, M.T., Modulation of endothelial cell migration and angiogenesis: A novel function for the “tandem-repeat” lectin galectin-8 (2011) FASEB J, 25 (1), pp. 242-254
• Deng, B., Zhu, J.M., Wang, Y., Liu, T.T., Ding, Y.B., Xiao, W.M., Lu, G.T., Shen, X.Z., Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-beta1 in gastric cancer (2013) Plos One, 8 (5)
• Dikov, M.M., Ohm, J.E., Ray, N., Tchekneva, E.E., Burlison, J., Moghanaki, D., Nadaf, S., Carbone, D.P., Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation (2005) J Immunol, 174 (1), pp. 215-222
• Dings, R.P., Loren, M., Heun, H., McNiel, E., Griffioen, A.W., Mayo, K.H., Griffin, R.J., Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization (2007) Clin Cancer Res, 13 (11), pp. 3395-3402
• Dobbelstein, M., Moll, U., Targeting tumour-supportive cellular machineries in anticancer drug development (2014) Nat Rev Drug Discov, 13 (3), pp. 179-196
• Ebos, J.M., Lee, C.R., Cruz-Munoz, W., Bjarnason, G.A., Christensen, J.G., Kerbel, R.S., Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis (2009) Cancer Cell, 15 (3), pp. 232-239
• Ellis, L.M., Hicklin, D.J., Pathways mediating resistance to vascular endothelial growth factor-targeted therapy (2008) Clin Cancer Res, 14 (20), pp. 6371-6375
• Facciabene, A., Peng, X., Hagemann, I.S., Balint, K., Barchetti, A., Wang, L.P., Gimotty, P.A., Coukos, G., Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(Reg) cells (2011) Nature, 475 (7355), pp. 226-230
• Fagiani, E., Bill, R., Pisarsky, L., Ivanek, R., Ruegg, C., Christofori, G., An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models (2015) Angiogenesis, 18 (3), pp. 327-345
• Ferrara, N., Adamis, A.P., Ten years of anti-vascular endothelial growth factor therapy (2016) Nat Rev Drug Discov, 15 (6), pp. 385-403
• Ferrara, N., Hillan, K.J., Novotny, W., Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy (2005) Biochem Biophys Res Commun, 333 (2), pp. 328-335
• Finke, J., Ko, J., Rini, B., Rayman, P., Ireland, J., Cohen, P., MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy (2011) Int Immunopharmacol, 11 (7), pp. 856-861
• Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Carmeliet, P., Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels (2007) Cell, 131 (3), pp. 463-475
• Folkman, J., Tumor angiogenesis: Therapeutic implications (1971) N Engl J Med, 285 (21), pp. 1182-1186
• Forget, M.A., Voorhees, J.L., Cole, S.L., Dakhlallah, D., Patterson, I.L., Gross, A.C., Moldovan, L., Eubank, T.D., Macrophage colony-stimulating factor augments Tie2-expressing monocyte differentiation, angiogenic function, and recruitment in a mouse model of breast cancer (2014) Plos One, 9 (6)
• Freeman, M.R., Schneck, F.X., Gagnon, M.L., Corless, C., Soker, S., Niknejad, K., Peoples, G.E., Klagsbrun, M., Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis (1995) Cancer Res, 55 (18), pp. 4140-4145
• Gabrilovich, D.I., Chen, H.L., Girgis, K.R., Cunningham, H.T., Meny, G.M., Nadaf, S., Kavanaugh, D., Carbone, D.P., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (1996) Nat Med, 2 (10), pp. 1096-1103
• Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D.P., Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo (1998) Blood, 92 (11), pp. 4150-4166
• Gabrilovich, D.I., Ishida, T., Nadaf, S., Ohm, J.E., Carbone, D.P., Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function (1999) Clin Cancer Res, 5 (10), pp. 2963-2970
• Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours (2012) Nat Rev Immunol, 12 (4), pp. 253-268
• Garber, K., Promising early results for immunotherapy-antiangiogenesis combination (2014) J Natl Cancer Inst, 106 (11)
• Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., Lechler, R.I., Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells (2007) Blood, 109 (5), pp. 2058-2065
• Gasparri, M.L., Bellati, F., Napoletano, C., Panici, P.B., Nuti, M., Interaction between Treg cells and angiogenesis: A dark double track (2013) Int J Cancer, 132 (10), p. 2469
• Ge, X.N., Ha, S.G., Greenberg, Y.G., Rao, A., Bastan, I., Blidner, A.G., Rao, S.P., Sriramarao, P., Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1 (2016) Proc Natl Acad Sci U S A, 113 (33), pp. E4837-E4846
• Giatromanolaki, A., Bates, G.J., Koukourakis, M.I., Sivridis, E., Gatter, K.C., Harris, A.L., Banham, A.H., The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer (2008) Gynecol Oncol, 110 (2), pp. 216-221
• Gotthardt, D., Putz, E.M., Grundschober, E., Prchal-Murphy, M., Straka, E., Kudweis, P., Heller, G., Sexl, V., STAT5 Is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion (2016) Cancer Discov, 6 (4), pp. 414-429
• Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Jung, S., Chimenti, S., Keshet, E., VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells (2006) Cell, 124 (1), pp. 175-189
• Gupta, S., Joshi, K., Wig, J.D., Arora, S.K., Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis (2007) Acta Oncol, 46 (6), pp. 792-797
• Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H.H., Rabie, T., Ganss, R., Vascular normalization in Rgs5-deficient tumours promotes immune destruction (2008) Nature, 453 (7193), pp. 410-414
• Hanahan, D., Coussens, L.M., Accessories to the crime: Functions of cells recruited to the tumor microenvironment (2012) Cancer Cell, 21 (3), pp. 309-322
• Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Mandelboim, O., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface (2006) Nat Med, 12 (9), pp. 1065-1074
• Hansen, W., Hutzler, M., Abel, S., Alter, C., Stockmann, C., Kliche, S., Albert, J., Helfrich, I., Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth (2012) J Exp Med, 209 (11), pp. 2001-2016
• Heddleston, J.M., Li, Z., Lathia, J.D., Bao, S., Hjelmeland, A.B., Rich, J.N., Hypoxia inducible factors in cancer stem cells (2010) Br J Cancer, 102 (5), pp. 789-795
• Heusschen, R., Schulkens, I.A., van Beijnum, J., Griffioen, A.W., Thijssen, V.L., Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis (2014) Biochim Biophys Acta, 1842 (2), pp. 284-292
• Hodi, F.S., Lawrence, D., Lezcano, C., Wu, X., Zhou, J., Sasada, T., Zeng, W., McDermott, D., Bevacizumab plus ipilimumab in patients with metastatic melanoma (2014) Cancer Immunol Res, 2 (7), pp. 632-642
• Holash, J., Davis, S., Papadopoulos, N., Croll, S.D., Ho, L., Russell, M., Boland, P., Rudge, J.S., VEGF-Trap: A VEGF blocker with potent antitumor effects (2002) Proc Natl Acad Sci U S A, 99 (17), pp. 11393-11398
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Jin, Y.T., Chen, Y.L., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27 (26), pp. 3746-3753
• Huang, Y., Yuan, J., Righi, E., Kamoun, W.S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Poznansky, M.C., Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy (2012) Proc Natl Acad Sci U S A, 109 (43), pp. 17561-17566
• Huang, Y., Goel, S., Duda, D.G., Fukumura, D., Jain, R.K., Vascular normalization as an emerging strategy to enhance cancer immunotherapy (2013) Cancer Res, 73 (10), pp. 2943-2948
• Hughes, P.E., Caenepeel, S., Wu, L.C., Targeted therapy and checkpoint immunotherapy combinations for the treatment of cancer (2016) Trends Immunol, 37 (7), pp. 462-476
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10 (9), pp. 981-991
• Jain, R.K., Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy (2005) Science, 307 (5706), pp. 58-62
• Jain, R.K., Antiangiogenesis strategies revisited: From starving tumors to alleviating hypoxia (2014) Cancer Cell, 26 (5), pp. 605-622
• Jeong, W., Doroshow, J.H., Kummar, S., United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies (2013) Curr Probl Cancer, 37 (3), pp. 110-144
• Jetten, N., Verbruggen, S., Gijbels, M.J., Post, M.J., de Winther, M.P., Donners, M.M., Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo (2014) Angiogenesis, 17 (1), pp. 109-118
• Ju, J.A., Godet, I., Ye, I.C., Byun, J., Jayatilaka, H., Lee, S.J., Xiang, L., Gilkes, D.M., Hypoxia selectively enhances integrin receptor expression to promote metastasis (2017) Mol Cancer Res
• Junttila, M.R., de Sauvage, F.J., Influence of tumour micro-environment heterogeneity on therapeutic response (2013) Nature, 501 (7467), pp. 346-354
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Shipp, M.A., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci U S A, 104 (32), pp. 13134-13139
• Kale, S., Hanai, J., Chan, B., Karihaloo, A., Grotendorst, G., Cantley, L., Sukhatme, V.P., Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression (2005) FASEB J, 19 (2), pp. 270-271
• Keith, B., Johnson, R.S., Simon, M.C., HIF1alpha and HIF2alpha: Sibling rivalry in hypoxic tumour growth and progression (2011) Nat Rev Cancer, 12 (1), pp. 9-22
• Kitamura, T., Qian, B.Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Pollard, J.W., CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages (2015) J Exp Med, 212 (7), pp. 1043-1059
• Knighton, D.R., Hunt, T.K., Scheuenstuhl, H., Halliday, B.J., Werb, Z., Banda, M.J., Oxygen tension regulates the expression of angiogenesis factor by macrophages (1983) Science, 221 (4617), pp. 1283-1285
• Kouo, T., Huang, L., Pucsek, A.B., Cao, M., Solt, S., Armstrong, T., Jaffee, E., Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells (2015) Cancer Immunol Res, 3 (4), pp. 412-423
• Krupitskaya, Y., Wakelee, H.A., Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer (2009) Curr Opin Investig Drugs, 10 (6), pp. 597-605
• Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., Yu, H., Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice (2008) J Clin Invest, 118 (10), pp. 3367-3377
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., Al Nakouzi, N., Rabinovich, G.A., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res, 73 (1), pp. 86-96
• Lagory, E.L., Giaccia, A.J., The ever-expanding role of HIF in tumour and stromal biology (2016) Nat Cell Biol, 18 (4), pp. 356-365
• Lau, K.S., Partridge, E.A., Grigorian, A., Silvescu, C.I., Reinhold, V.N., Demetriou, M., Dennis, J.W., Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation (2007) Cell, 129 (1), pp. 123-134
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Zhao, S., Koong, A.C., Galectin-1: A link between tumor hypoxia and tumor immune privilege (2005) J Clin Oncol, 23 (35), pp. 8932-8941
• Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., Ferrara, N., Vascular endothelial growth factor is a secreted angiogenic mitogen (1989) Science, 246 (4935), pp. 1306-1309
• Lewis, C.E., Pollard, J.W., Distinct role of macrophages in different tumor microenvironments (2006) Cancer Res, 66 (2), pp. 605-612
• Lin, E.Y., Li, J.F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D.A., Qian, H., Pollard, J.W., Macrophages regulate the angiogenic switch in a mouse model of breast cancer (2006) Cancer Res, 66 (23), pp. 11238-11246
• Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat Rev Cancer, 5 (1), pp. 29-41
• Liu, X.D., Hoang, A., Zhou, L., Kalra, S., Yetil, A., Sun, M., Ding, Z., Jonasch, E., Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma (2015) Cancer Immunol Res, 3 (9), pp. 1017-1029
• Loges, S., Mazzone, M., Hohensinner, P., Carmeliet, P., Silencing or fueling metastasis with VEGF inhibitors: Antiangiogenesis revisited (2009) Cancer Cell, 15 (3), pp. 167-170
• Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R.H., Sitkovsky, M., Cutting edge: Hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes (2006) J Immunol, 177 (8), pp. 4962-4965
• Luo, W., Song, L., Chen, X.L., Zeng, X.F., Wu, J.Z., Zhu, C.R., Huang, T., Wu, X.P., Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells (2016) Oncotarget, 7 (18), pp. 26709-26723
• Lykken, J.M., Horikawa, M., Minard-Colin, V., Kamata, M., Miyagaki, T., Poe, J.C., Tedder, T.F., Galectin-1 drives lymphoma CD20 immunotherapy resistance: Validation of a preclinical system to identify resistance mechanisms (2016) Blood, 127 (15), pp. 1886-1895
• Machado, C.M., Andrade, L.N., Teixeira, V.R., Costa, F.F., Melo, C.M., Dos Santos, S.N., Nonogaki, S., Chammas, R., Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFbeta1-induced macrophages (2014) Cancer Med, 3 (2), pp. 201-214
• Mamessier, E., Sylvain, A., Thibult, M.L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Goncalves, A., Olive, D., Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity (2011) J Clin Invest, 121 (9), pp. 3609-3622
• Manegold, C., Dingemans, A.C., Gray, J.E., Nakagawa, K., Nicolson, M., Peters, S., Reck, M., Vokes, E., The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC (2017) J Thorac Oncol, 12 (2), pp. 194-207
• Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., Allavena, P., Tumour-associated macrophages as treatment targets in oncology (2017) Nat Rev Clin Oncol
• Manzi, M., Bacigalupo, M.L., Carabias, P., Elola, M.T., Wolfenstein-Todel, C., Rabinovich, G.A., Espelt, M.V., Troncoso, M.F., Galectin-1 controls the proliferation and migration of liver sinusoidal endothelial cells and their interaction with hepatocarcinoma cells (2016) J Cell Physiol, 231 (7), pp. 1522-1533
• Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF-and bFGF-mediated angiogenic response (2010) J Exp Med, 207 (9), pp. 1981-1993
• Markowska, A.I., Jefferies, K.C., Panjwani, N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells (2011) J Biol Chem, 286 (34), pp. 29913-29921
• Marone, G., Varricchi, G., Loffredo, S., Granata, F., Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis (2016) Eur J Pharmacol, 778, pp. 146-151
• Martinez-Bosch, N., Fernandez-Barrena, M.G., Moreno, M., Ortiz-Zapater, E., Munne-Collado, J., Iglesias, M., Andre, S., Navarro, P., Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation (2014) Cancer Res, 74 (13), pp. 3512-3524
• Mathieu, V., de Lassalle, E.M., Toelen, J., Mohr, T., Bellahcene, A., van Goietsenoven, G., Verschuere, T., Feron, O., Galectin-1 in melanoma biology and related neo-angiogenesis processes (2012) J Invest Dermatol, 132 (9), pp. 2245-2254
• Melero, I., Berman, D.M., Aznar, M.A., Korman, A.J., Perez Gracia, J.L., Haanen, J., Evolving synergistic combinations of targeted immunotherapies to combat cancer (2015) Nat Rev Cancer, 15 (8), pp. 457-472
• Mendez-Huergo, S.P., Blidner, A.G., Rabinovich, G.A., Galectins: Emerging regulatory checkpoints linking tumor immunity and angiogenesis (2017) Curr Opin Immunol, 45, pp. 8-15
• Mimura, K., Kono, K., Takahashi, A., Kawaguchi, Y., Fujii, H., Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2 (2007) Cancer Immunol Immunother, 56 (6), pp. 761-770
• Mizukami, Y., Jo, W.S., Duerr, E.M., Gala, M., Li, J., Zhang, X., Zimmer, M.A., Chung, D.C., Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells (2005) Nat Med, 11 (9), pp. 992-997
• Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation (2008) Nat Rev Immunol, 8 (12), pp. 958-969
• Motz, G.T., Coukos, G., The parallel lives of angiogenesis and immunosuppression: Cancer and other tales (2011) Nat Rev Immunol, 11 (10), pp. 702-711
• Motz, G.T., Coukos, G., Deciphering and reversing tumor immune suppression (2013) Immunity, 39 (1), pp. 61-73
• Murdoch, C., Giannoudis, A., Lewis, C.E., Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues (2004) Blood, 104 (8), pp. 2224-2234
• Murdoch, C., Muthana, M., Coffelt, S.B., Lewis, C.E., The role of myeloid cells in the promotion of tumour angiogenesis (2008) Nat Rev Cancer, 8 (8), pp. 618-631
• Myszczyszyn, A., Czarnecka, A.M., Matak, D., Szymanski, L., Lian, F., Kornakiewicz, A., Bartnik, E., Szczylik, C., The role of hypoxia and cancer stem cells in renal cell carcinoma pathogenesis (2015) Stem Cell Rev, 11 (6), pp. 919-943
• Nabi, I.R., Shankar, J., Dennis, J.W., The galectin lattice at a glance (2015) J Cell Sci, 128 (13), pp. 2213-2219
• Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Raz, A., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am J Pathol, 156 (3), pp. 899-909
• Noman, M.Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., Chouaib, S., PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation (2014) J Exp Med, 211 (5), pp. 781-790
• Noy, R., Pollard, J.W., Tumor-associated macrophages: From mechanisms to therapy (2014) Immunity, 41 (1), pp. 49-61
• Osada, T., Chong, G., Tansik, R., Hong, T., Spector, N., Kumar, R., Hurwitz, H.I., Morse, M.A., The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients (2008) Cancer Immunol Immunother, 57 (8), pp. 1115-1124
• Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Vinals, F., Inoue, M., Casanovas, O., Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis (2009) Cancer Cell, 15 (3), pp. 220-231
• Pan, F., Barbi, J., Pardoll, D.M., Hypoxia-inducible factor 1: A link between metabolism and T cell differentiation and a potential therapeutic target (2012) Oncoimmunology, 1 (4), pp. 510-515
• Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy (2012) Nat Rev Cancer, 12 (4), pp. 252-264
• Piao, Y., Liang, J., Holmes, L., Zurita, A.J., Henry, V., Heymach, J.V., de Groot, J.F., Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype (2012) Neuro-Oncology, 14 (11), pp. 1379-1392
• Piccolo, E., Tinari, N., Semeraro, D., Traini, S., Fichera, I., Cumashi, A., la Sorda, R., Iacobelli, S., LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis (2013) J Mol Med (Berlin), 91 (1), pp. 83-94
• Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., Andre, P., Cremer, I., Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma (2011) Cancer Res, 71 (16), pp. 5412-5422
• Potente, M., Gerhardt, H., Carmeliet, P., Basic and therapeutic aspects of angiogenesis (2011) Cell, 146 (6), pp. 873-887
• Priceman, S.J., Sung, J.L., Shaposhnik, Z., Burton, J.B., Torres-Collado, A.X., Moughon, D.L., Johnson, M., Wu, L., Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: Combating tumor evasion of antiangiogenic therapy (2010) Blood, 115 (7), pp. 1461-1471
• Quail, D.F., Joyce, J.A., Microenvironmental regulation of tumor progression and metastasis (2013) Nat Med, 19 (11), pp. 1423-1437
• Rabinovich, G.A., Conejo-Garcia, J.R., Shaping the immune landscape in cancer by galectin-driven regulatory pathways (2016) J Mol Biol, 428 (16), pp. 3266-3281
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36 (3), pp. 322-335
• Rabinovich, G., Castagna, L., Landa, C., Riera, C.M., Sotomayor, C., Regulated expression of a 16-kd galectin-like protein in activated rat macrophages (1996) J Leukoc Biol, 59 (3), pp. 363-370
• Rabinovich, G.A., Gabrilovich, D., Sotomayor, E.M., Immunosuppressive strategies that are mediated by tumor cells (2007) Annu Rev Immunol, 25, pp. 267-296
• Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Kuchroo, V.K., Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion (2012) Nat Med, 18 (9), pp. 1394-1400
• Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M.L., Carmeliet, P., HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF (2011) Cancer Cell, 19 (1), pp. 31-44
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5 (3), pp. 241-251
• Rutkowski, M.R., Stephen, T.L., Svoronos, N., Allegrezza, M.J., Tesone, A.J., Perales-Puchalt, A., Brencicova, E., Conejo-Garcia, J.R., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation (2015) Cancer Cell, 27 (1), pp. 27-40
• Sato, S., Nieminen, J., Seeing strangers or announcing “danger”: Galectin-3 in two models of innate immunity (2004) Glycoconj J, 19 (7-9), pp. 583-591
• Semenza, G.L., Hypoxia-inducible factors: Coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype (2017) EMBO J, 36 (3), pp. 252-259
• Sharma, P., Hu-Lieskovan, S., Wargo, J.A., Ribas, A., Primary, adaptive, and acquired resistance to cancer immunotherapy (2017) Cell, 168 (4), pp. 707-723
• Shehade, H., Acolty, V., Moser, M., Oldenhove, G., Cutting edge: Hypoxia-inducible factor 1 negatively regulates Th1 function (2015) J Immunol, 195 (4), pp. 1372-1376
• Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D.R., Chi, H., HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells (2011) J Exp Med, 208 (7), pp. 1367-1376
• Shojaei, F., Wu, X., Malik, A.K., Zhong, C., Baldwin, M.E., Schanz, S., Fuh, G., Ferrara, N., Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (2007) Nat Biotechnol, 25 (8), pp. 911-920
• Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.H., Yao, J., Blanchard, D., Ferrara, N., Bv8 regulates myeloid-cell-dependent tumour angiogenesis (2007) Nature, 450 (7171), pp. 825-831
• Shojaei, F., Singh, M., Thompson, J.D., Ferrara, N., Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression (2008) Proc Natl Acad Sci U S A, 105 (7), pp. 2640-2645
• Shojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y.G., Ferrara, N., G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models (2009) Proc Natl Acad Sci U S A, 106 (16), pp. 6742-6747
• Shojaei, F., Lee, J.H., Simmons, B.H., Wong, A., Esparza, C.O., Plumlee, P.A., Feng, J., Christensen, J.G., HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors (2010) Cancer Res, 70 (24), pp. 10090-10100
• Shrestha, B., Hashiguchi, T., Ito, T., Miura, N., Takenouchi, K., Oyama, Y., Kawahara, K., Maruyama, I., B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes (2010) J Immunol, 184 (9), pp. 4819-4826
• Siveen, K.S., Kuttan, G., Role of macrophages in tumour progression (2009) Immunol Lett, 123 (2), pp. 97-102
• Song, N., Huang, Y., Shi, H., Yuan, S., Ding, Y., Song, X., Fu, Y., Luo, Y., Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/ CXCR4 axis (2009) Cancer Res, 69 (15), pp. 6057-6064
• Soucek, L., Lawlor, E.R., Soto, D., Shchors, K., Swigart, L.B., Evan, G.I., Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors (2007) Nat Med, 13 (10), pp. 1211-1218
• Sozzani, S., Rusnati, M., Riboldi, E., Mitola, S., Presta, M., Dendritic cell-endothelial cell crosstalk in angiogenesis (2007) Trends Immunol, 28 (9), pp. 385-392
• Stockmann, C., Schadendorf, D., Klose, R., Helfrich, I., The impact of the immune system on tumor: Angiogenesis and vascular remodeling (2014) Front Oncol, 4
• Tan, C., Cruet-Hennequart, S., Troussard, A., Fazli, L., Costello, P., Sutton, K., Wheeler, J., Dedhar, S., Regulation of tumor angiogenesis by integrin-linked kinase (ILK) (2004) Cancer Cell, 5 (1), pp. 79-90
• Tang, D., Gao, J., Wang, S., Ye, N., Chong, Y., Huang, Y., Wang, J., Wang, D., Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression (2016) Tumour Biol, 37 (2), pp. 1889-1899
• von Tell, D., Armulik, A., Betsholtz, C., Pericytes and vascular stability (2006) Exp Cell Res, 312 (5), pp. 623-629
• Tesone, A.J., Rutkowski, M.R., Brencicova, E., Svoronos, N., Perales-Puchalt, A., Stephen, T.L., Allegrezza, M.J., Conejo-Garcia, J.R., Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells (2016) Cell Rep, 14 (7), pp. 1774-1786
• Thiemann, S., Baum, L.G., Galectins and immune responses-just how do they do those things they do? (2016) Annu Rev Immunol, 34, pp. 243-264
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Griffioen, A.W., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci U S A, 103 (43), pp. 15975-15980
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Hackeng, T.M., Griffioen, A.W., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70 (15), pp. 6216-6224
• Thijssen, V.L., Rabinovich, G.A., Griffioen, A.W., Vascular galectins: Regulators of tumor progression and targets for cancer therapy (2013) Cytokine Growth Factor Rev, 24 (6), pp. 547-558
• Triner, D., Shah, Y.M., Hypoxia-inducible factors: A central link between inflammation and cancer (2016) J Clin Invest, 126 (10), pp. 3689-3698
• Verschuere, T., Toelen, J., Maes, W., Poirier, F., Boon, L., Tousseyn, T., Mathivet, T., de Vleeschouwer, S., Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity (2014) Int J Cancer, 134 (4), pp. 873-884
• Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.L., Latreche, S., Terme, M., VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors (2015) J Exp Med, 212 (2), pp. 139-148
• Wallin, J.J., Bendell, J.C., Funke, R., Sznol, M., Korski, K., Jones, S., Hernandez, G., McDermott, D.F., Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma (2016) Nat Commun, 7
• Wang, F., Lv, P., Gu, Y., Li, L., Ge, X., Guo, G., Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway (2017) Oncotarget
• Wei, J., Wu, A., Kong, L.Y., Wang, Y., Fuller, G., Fokt, I., Melillo, G., Heimberger, A.B., Hypoxia potentiates glioma-mediated immunosuppression (2011) Plos One, 6 (1)
• Winkler, E.A., Bell, R.D., Zlokovic, B.V., Central nervous system pericytes in health and disease (2011) Nat Neurosci, 14 (11), pp. 1398-1405
• Wu, X., Giobbie-Hurder, A., Liao, X., Lawrence, D., McDermott, D., Zhou, J., Rodig, S., Hodi, F.S., VEGF neutralization plus CTLA-4 blockade alters soluble and cellular factors associated with enhancing lymphocyte infiltration and humoral recognition in melanoma (2016) Cancer Immunol Res, 4 (10), pp. 858-868
• Yang, L., Debusk, L.M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L.M., Lin, P.C., Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis (2004) Cancer Cell, 6 (4), pp. 409-421
• Yang, M., Ma, C., Liu, S., Shao, Q., Gao, W., Song, B., Sun, J., Qu, X., HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia (2010) Immunol Cell Biol, 88 (2), pp. 165-171
• Yang, C., Lee, H., Pal, S., Jove, V., Deng, J., Zhang, W., Hoon, D.S., Yu, H., B cells promote tumor progression via STAT3 regulated-angiogenesis (2013) Plos One, 8 (5)
• Yasuda, S., Sho, M., Yamato, I., Yoshiji, H., Wakatsuki, K., Nishiwada, S., Yagita, H., Nakajima, Y., Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo (2013) Clin Exp Immunol, 172 (3), pp. 500-506
• Zhao, X.Y., Chen, T.T., Xia, L., Guo, M., Xu, Y., Yue, F., Jiang, Y., Zhao, K.W., Hypoxia inducible factor-1 mediates expression of galectin-1: The potential role in migration/invasion of colorectal cancer cells (2010) Carcinogenesis, 31 (8), pp. 1367-1375
• Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., Zheng, X.X., Kuchroo, V.K., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity (2005) Nat Immunol, 6 (12), pp. 1245-1252
• Zucchetti, M., Bonezzi, K., Frapolli, R., Sala, F., Borsotti, P., Zangarini, M., Cvitkovic, E., Taraboletti, G., Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib (2013) Cancer Chemother Pharmacol, 72 (4), pp. 879-887

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------